Brief: Tenaya Therapeutics Reports Q3 2022 Financial Results And Provides Business Update
10/11/2022 21:56
Nov 10 (Reuters) - Tenaya Therapeutics Inc TNYA.O :
* TENAYA THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* AS OF SEPTEMBER 30, 2022, CASH, CASH EQUIVALENTS AND
INVESTMENTS
IN MARKETABLE SECURITIES WERE $149.5 MILLION
* NET LOSS FOR Q2 ENDED SEPTEMBER 30, 2022, WAS $30.7
MILLION, OR
$0.74 PER SHARE
* Q3 EARNINGS PER SHARE VIEW $-0.64 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX205jhf
Further company coverage: TNYA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Tenaya Therapeutics
See all newsBrief: Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment Of Mybpc3-Associated Hcm With TN-201 Gene Therapy Resulted In Consistent Signs Of Cardiac Remodeling And Reductions In Symptoms
Brief: Positive Interim Data From Cohorts 1 And 2 Of Tenaya's Ridge-1 Phase 1B/2 Clinical Trial Of TN-401
Tenaya Therapeutics Q1 net loss widens, misses analyst expectations
Brief: Tenaya Therapeutics Q1 Net Income USD -19.272 Million
Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027